Ahmedabad-based Veeda Clinical Research has entered into a collaborative agreement with the Ministry of Health, Malaysia, to open a Phase I and Early Clinical Development unit at Ampang Hospital in Kuala Lumpur.
The Ministry of Health in Malaysia has been promoting formation of clinical research offices in all major Malaysian hospitals.
The unit, in one of the hospital’s wards, will have a 28-bed facility for Phase I studies and also experimental medicine studies. The unit will initially have 12 fully monitored beds. It is expected to provide more services locally from within Malaysia as it grows.
According to Maurice Cross, group medical director of Veeda Clinical Research, the opening of the Ampang Unit towards the end of this year will provide not only a facility for the global pharmaceutical industry but will also be a major contributor to the training of a cadre of Malaysians capable of performing this type of work and will also play its part in attracting many pharmaceutical companies to look at Malaysia as a base in Southeast Asia.
